Moving Closer to Personalized Cancer Prevention Strategies by Assessing Comorbidity and Multimorbidity

A study by Lavery et al., published in JAMA Network Open, used data from the PLCO screening trial to investigate how midlife comorbidities affect cancer risk and mortality. While comorbidities like cardiovascular and respiratory diseases were linked to certain cancer types and higher cancer death rates, they had limited association with overall cancer risk. The commentary highlights the importance of considering multimorbidity—multiple coexisting conditions—rather than analyzing single comorbidities in isolation. It calls for more advanced, personalized research methods and emphasizes the influence of socioeconomic and healthcare factors on cancer outcomes.

Koroukian SM, Kim U, Rose J. Moving Closer to Personalized Cancer Prevention Strategies by Assessing Comorbidity and Multimorbidity. JAMA Netw Open. 2025;8(4):e253476. doi:10.1001/jamanetworkopen.2025.3476